CASI Pharmaceuticals Inc CASI
$0.21 $0.59 (74.06%) 1D
Last Updated: Feb 25, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
CASI Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, CASI Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
CASI Pharmaceuticals Inc. Stock Analysis CASI
United States Health Care Nano Cap CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 233 full-time employees. The company went IPO on 2021-08-23. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The firm mainly conducts its business in the domestic market.
CASI Pharmaceuticals Inc (CASI) Chart
Financial Metrics & Statements of CASI Pharmaceuticals Inc (CASI)
FAQ's for CASI Pharmaceuticals Inc (CASI)
- As of August 2026, CASI Pharmaceuticals Inc CASI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CASI Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in CASI Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CASI Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CASI Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CASI Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for CASI Pharmaceuticals Inc (CASI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
